IPCA Laboratories Ltd launches Diulcus® to address Diabetic Foot Ulcer in India
Diulcus®, developed by NovaLead Pharma, shows promising results in clinical trials with a 77.20% ulcer closure rate New Delhi [India], August 27: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, with an additional 13.6 crore people affected by pre-diabetes. This significant health concern positions India to become the diabetes capital of the world by 2030. In […]
Continue Reading